NCT04673695View on ClinicalTrials.gov

A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344

PHASE1UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 13, 2020

Primary Completion Date

December 26, 2020

Study Completion Date

January 2, 2021

Conditions
Anticoagulant
Interventions
DRUG

Lixiana(D006)

NOAC(Factor Xa inhibitor)

DRUG

CKD-344

NOAC(Factor Xa inhibitor)

Trial Locations (1)

Unknown

RECRUITING

Yook-Hwan Noh, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT04673695 - A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 | Biotech Hunter | Biotech Hunter